52 Week Range
As of on the New York Stock Exchange ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
UnitedHealth Group Says Stephen J. Hemsley Has Decided To Transition From His Management Position As Executive Chair
Unitedhealth Group Sets Quarterly Cash Dividend Of $1.08 per Share
UnitedHealth Group's Optum Division Acquired Vivify Health- CNBC
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. OptumInsight provides services, technology and healthcare solutions to participants in the healthcare industry. OptumRx provides retail network contracting, purchasing and clinical solutions.
Insurance (Accident & Health)
9900 Bren Rd E
Stephen J. Hemsley
Executive Chairman of the Board
Andrew Philip Witty
Group President, Chief Executive Officer, Executive Vice President, Director
David Scott Wichmann
Chief Executive Officer, Director
John F. Rex
Chief Financial Officer, Executive Vice President
Marianne D. Short
Executive Vice President, Chief Legal Officer
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
UnitedHealth Group Inc on Tuesday provided an optimistic outlook for 2020 profit, saying it expected growth to be at least 13%, which outpaces current Wall Street estimates and sent its shares up as much as 8.6%.
U.S. stocks opened higher on Tuesday, as strong earnings reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson allayed concerns about the fallout from a prolonged U.S.-China trade war on corporate America.
UnitedHealth expects 2020 adjusted earnings growth in the low end of its long-term growth range of 13% to 16%, Chief Executive Officer Dave Wichmann said during a conference call, above the 11 percent rate of growth represented by the midpoint of current analyst consensus.
U.S. stock index futures rose on Tuesday, as the third-quarter earnings season got off to an upbeat start with robust reports from JPMorgan Chase, UnitedHealth and Johnson & Johnson.
UnitedHealth Group Inc reported an 11% rise in third-quarter profit on Tuesday, helped by higher revenue in its core business that sells health plans, and strength in its Optum unit, which includes its pharmacy benefits management business.
UnitedHealth Group Inc <UNH.N> will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday.
UnitedHealth Group Inc will stick to its plan to implement point-of-sale rebates to all its members, Chief Executive Officer David Wichmann said on Thursday.
UnitedHealth Group Inc reported a 12.7% rise in second-quarter profit on Thursday, as the company added more members to its health plans and revenue climbed in its Optum unit, which includes its pharmacy benefit management business.
UnitedHealth Group Inc has agreed to buy healthcare payments firm Equian LLC from its private-equity owner New Mountain Capital for about $3.2 billion, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
UnitedHealth Group Inc has agreed to buy health-care payments firm Equian LLC from its private-equity owner New Mountain Capital for about $3.2 billion, the Wall Street Journal reported on Thursday, citing people familiar with the matter.
UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.
UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)
* UNITEDHEALTH EXECUTIVE ANDREW WITTY FLAGS "REAL RISK" OF PRICE INFLATION IF EFFECTIVE NEW SYSTEM TO REPLACE CURRENT REBATES IS NOT PUT IN PLACE- CONF. CALL
UnitedHealth Group Inc said on Tuesday it expects minimal impact to its margins if the rebate system is overhauled but investors remained concerned about the impact of the Trump administration's proposal to end discounts from drugmakers.
U.S. stocks opened higher on Tuesday, taking the S&P 500 to less than a percent away from an all-time high, after better-than-expected results from healthcare giants UnitedHealth and Johnson & Johnson.
U.S. health insurer UnitedHealth Group Inc on Tuesday reported a 22.2 percent rise in first-quarter profit, driven by strength in its main insurance business and Optum unit, which includes its pharmacy benefit management business.
The U.S. House Committee on Energy and Commerce on Wednesday launched an investigation into 12 health insurers, including Anthem Inc and UnitedHealth Group, over their sale of short-term plans.
UnitedHealth Group Inc said on Tuesday that starting next year it will expand its drug discount program to all new employer-sponsored health plans and pass on rebates to consumers.
UnitedHealth Group Inc said on Tuesday it would expand from January 2020 its point-of-sale discount program to all new employer-sponsored plans in an effort to make drugs more affordable for patients. The insurer also said that existing members would have the choice of adopting...
UnitedHealth Group Inc, the largest U.S. health insurer, beat Wall Street estimates for fourth-quarter profit on Tuesday, driven largely by growth in its Optum services business, including its pharmacy benefits unit.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.